HT
AMED

HAP Trading’s Amedisys AMED Stock Holding History

HAP Trading’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-19,500
Closed -$20.1K – 702
2024
Q4 		$20.1K Sell
19,500
-29,400
-60% -$2.7M ﹤0.01% 566
2024
Q3 		$6.25K Sell
48,900
-1,100
-2% -$107K ﹤0.01% 620
2024
Q2 		$8.75K Hold
50,000
– – ﹤0.01% 582
2024
Q1 		$13.8K Sell
50,000
-800
-2% -$75K ﹤0.01% 563
2023
Q4 		$18K Buy
+50,800
New +$4.74M ﹤0.01% 612
2014
Q1 		– Sell
-61,700
Closed -$68K – 993
2013
Q4 		$68K Buy
+61,700
New +$993K ﹤0.01% 846

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

HAP Trading's AMED Position: Q2 2025 in Review

HAP Trading sold out of Amedisys (AMED) in Q2 2025, closing a stake of 32,422 shares — an estimated $3.07M sold.

HAP Trading first reported a position in AMED in Q1 2025 and held it in 1 quarter. The position peaked at $3M in Q1 2025. 320 funds tracked by Wall St. Rank hold AMED as of Q2 2025.

  • HAP Trading reported no remaining Amedisys position as of Q2 2025 after selling out during the quarter.
  • HAP Trading sold 32,422 Amedisys shares in Q2 2025, an estimated $3.07M.
  • HAP Trading first reported a position in Amedisys in Q1 2025 and held it in 1 quarter.
  • HAP Trading's Amedisys position peaked at $3M in Q1 2025.
  • 320 funds tracked by Wall St. Rank held Amedisys as of Q2 2025.

Based on HAP Trading's 13F filing for Q2 2025, filed 13 Aug 2025.